The incidences of upper gastrointestinal and colorectal malignancies in Ağrı city of eastern Anatolia
Abstract
Objective: Gastrointestinal tract malignancies comprise essential morbidity and mortality reasons in east Anatolia. The data regarding the incidences and clinical symptoms of these malignancies in this region are scarce.
Method: All endoscopic interventions and obtained biopsies between July 2014 and August 2015 were reviewed retrospectively. Age-adjusted and crude incidences were calculated according to the mid- population number in 2014 given by the regional governorship.
Results: A total of 1176 endoscopic interventions (927 (78.8%) upper endoscopy and 249 (21.2%) colonoscopy) were performed within 12 months of time interval. As a result of these endoscopic interventions, 14 (19.1%) esophageal cancers, 49 (67.1%) gastric cancers, and 10 (13.6%) colorectal cancers were diagnosed. Crude incidences per 100.000 individuals for esophageal cancer were 2.4 and 2.6, for gastric cancer were 9.1 and 8.3, and for colorectal cancer were 2.8 and 0.7 for men and women, respectively. Gender and age-adjusted esophageal cancer rates per 100.000 individuals for men between 30-34 years was 0.34 and for women between 40-44 years was 3.03. While weight loss was more common in upper gastrointestinal malignancies (49.2% vs. 10%, p<0.001), anemia was more common in colorectal malignancies (90% vs. 15.8%, p=0.02).
Conclusions: When age-adjusted cancer rates were taken into consideration, the esophageal cancer rate in young men and women was shown to be increased in Ağrı province, contrary to Turkey’s general. Despite an increase in the crude incidence of gastric cancer, when adjusted to age, the incidence seems to be in accordance with the general tendency.
Keywords
Kaynakça
- 1. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12–20.
- 2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;6:69–90.
- 3. Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239-248.
- 4. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. The Surgical Clinics of North America 2012; 92:1077–87.
- 5. GLOBOCAN. Estimated number of colorectal cancer new cases in 2018, worldwide, both sexes, all ages Cancer Today 2018 [cited 2018 October,19, 2018]; Available from: https://gco.iarc.fr/today/ online-analysis table?v=2018 &mode= cancer&mode_population= continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D= 17&nb_items=5&group_cancer=1&include_nmsc=1&include_ nmsc_other=1.
- 6. Bray, F. , Ferlay, J. , Soerjomataram, I. , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018; 68: 394-424. doi:10.3322/caac.214927.
- 7. Boyle P, Longman JS. ABC of colrectal cancer: Epidemiology. BMJ 2000; 321: 805-8.
- 8. HSGM. Cancer Statistics of Turkey in 2014. https://hsgm.saglik.gov.tr/tr/kanser istatistikleri/yillar/495-2014-y%C4%B1l%C4%B1-t%C3%BCrkiye-kanser-istatistikleri.html
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Erkan Çağlar
*
0000-0001-7246-0952
Türkiye
Kadir Balaban
Türkiye
Aslı Sezgin Çağlar
Abdurrahman Akay
Yayımlanma Tarihi
30 Eylül 2019
Gönderilme Tarihi
12 Ağustos 2019
Kabul Tarihi
25 Eylül 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 41 Sayı: 3